Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Alemtuzumab Improves Patient-Reported Quality of Life Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients With Highly Active Disease: Results From the CARE-MS II Extension Study
Multiple Sclerosis
P5 - (-)
367
Authors/Disclosures
Rafael Arroyo Gonzalez
PRESENTER
Rafael Arroyo Gonzalez has nothing to disclose.
Jennifer Guo (Sanofi) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Maria J. Melanson, MD No disclosure on file
David Cella, PhD (Northwestern Feinberg School of Medicine) No disclosure on file
No disclosure on file